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Abstract 
  Objectives.  To characterize K. pneumoniae isolates presenting 
decreased susceptibility to third generation cephalosporins, and isolated in 
two high risk units of the University of the Andes Hospital (HULA).  
Methods. We studied all the K. pneumoniae strains non-susceptible to third 
generation cephalosporins isolated from patients and the environment in the 
Neonatal High Risk Unit (NHRU) and Adult Intensive Care Unit (AICU) of 
the HULA in Merida, Venezuela, from  February to March 2007, and from 
June to November 2009. Antibiotic susceptibility was tested by the disk-
diffusion method and by the E-test method.  Detection of blaβLEE and blaAmpC 
genes was carried out by PCR and sequencing. The genetic relationship 
between the isolates was established by pulsed field gel Electrophoresis 
(PFGE) and Multilocus Sequence Typing (MLST).  
Results. In total 39 isolates non-susceptible to  third generation 
cephalosporins were identified, 30 of them from the NHRU and 9 from the 
AICU;  20 isolates (51,28%) produced CTX-M-15, 8 (20,51 %) CTX-M-2, 8 
(20,51%) SHV-12, 2 (5,12%)  SHV-1 overproduction and 1 (2.56%) EBC.  
By PFGE, ten clusters were found. By MLST, the two more prevalent PFGE 
clusters belonged to ST70, (here reported for the first time in Venezuela), 
and ST126.  
Conclusions. Its to seem to be the first time, the dissemination of the ST70 
clone producing CTX-M-15 in different risk units of LAUH is being 
described in Venezuela; also this is the first worldwide description the 
ST1261 clone producing CTX-M-2 and SHV-2. 
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Introduction 
Klebsiella pneumoniae is one of the primary agents of pneumonia, 
septicemia, and other frequent nosocomial infections (Perlman et al., 2007; 
Alonso et al., 2005). The rapid spread of K. pneumoniae strains that are 
resistant to multiple families of antibiotics, such as carbapenems and third-
generation cephalosporins, is of great concern worldwide (Lynch et al., 
2013). Initially, this resistance was associated with SHV-1 or TEM-1 
extended-spectrum beta-lactamase (ESBL)-producing strains that caused 
hospital outbreaks. However, the increased production of CTX-M–type 
ESBL-producing strains has been reported in recent years. The CTX-M type 
is associated with certain genetic elements, such as insertion sequences, 
transposons, and plasmids (Vignoli et al., 2006).In Mérida, Venezuela, the 
simultaneous presence of TEM-1 and SHV-5 was reported in K. pneumoniae 
strains isolated during a nosocomial outbreak in 2000 (Araque and  Rivera, 
2004). A 2010 study also from Mérida detected CTX-M-1 and CTX-M-2 
ESBLs in K. pneumoniae strains isolated from high-risk newborn infants 
(Millan et al., 2013). Other studies in Caracas reported the presence of TEM-
1, SHV-1, and CTX-M-2 in Enterobacteriaceae of hospital origin (Guzman 
and Alonso, 2009; Torres et al., 2006). During 2007 and 2009 in a university 
hospital in Mérida, researchers isolated multidrug resistant K. pneumoniae 
strains producing ESBLs, TEM, SHV, and CTX (González et al., 2011; 
González et al., 2013). 
The objective of this study was to characterize the genotypes of K. 
pneumoniae strains with reduced sensitivity to third-generation 
cephalosporins, which were isolated from the neonatal high-risk unit 
(NHRU) in 2007 and 2009 and from the adult intensive care unit (AICU) in 
2009 at the Los Andes University Hospital (LAUH) in Mérida, Venezuela. 
The overall aim was to study the distribution and spread of these strains by 
using specific molecular techniques 
 
Materials and methods 
Study Design and Bacterial Strains 
Strains were isolated in February 2007 during a10-day outbreak in 
the High-Risk Neonatology Unit (HRNU) of the Hospital of the University 
of the Andes (HULA) in Venezuela. K. penumoniae strains with diminished 
sensitivity to cefotaxime or ceftazidime were selected from newborns 
hospitalized between February and March 2007. Strains were also isolated 
during environmental microbiologic sampling and from the hands of staff 
members, to determine possible sources of infection (González et al., 2011). 
In total,16 K. pneumonia strains were isolated from the HRNU in 2007.  
A second sampling was conducted atthe HRNU with the same 
selection criteria from June to November 2009 (González et al., 2013). A 
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total of 14 K. pneumoniae strains were selected from this sampling. In 
addition, 9 strains with the same resistance pattern that were isolated from 
patients admitted to the Adult Intensive Care Unit (AICU) from June to 
November 2009 were included in the study. The AICU strains were included 
to detect the possible spread of K. pneumoniae strains with diminished 
sensitivity to third-generation cephalosporins across other HULA units. The 
microbiologic study was conducted at the “Dr. Roberto Gabaldón” 
Bacteriology Laboratory of the Department of Microbiology and 
Parasitology of the School of Pharmacy and Bioanalysis of the University of 
the Andes. The study of resistance mechanisms and molecular epidemiology 
was performed at the National Center of Microbiology of the Carlos III 
Health Institute. 
 
Susceptibility to antimicrobial agents 
Antimicrobial sensitivity was assessed with the disk-diffusion 
sensitivity test in Mueller-Hinton agar. The minimum inhibitory 
concentration (MIC) was determined via Etest® (BioMérieux, France),in 
accordance with the manufacturer’s instructions. Strain sensitivity was 
determined via cut-off points. Strains with intermediate sensitivity or with 
resistance to cefotaxime or ceftazidime based on CLSI, (2013) were 
considered to have diminished sensitivity to third-generation cephalosporins. 
To confirm production of ESBL,cefotaxime and ceftazidime slides were 
used, alone or in combination with clavulanic acid, according to the 
manufacturers’ instructions (CLSI., 2013). 
AmpC production was suspected for strains that were resistant to 
cefoxitin and amoxicillin/clavulanic acid and that did not regain cefotaxime 
or ceftazidime activity with clavulanic acid. For phenotype confirmation of 
AmpC,the DDT test was performed, combined with phenylboronic acid as an 
inhibitor and cefoxitin (Yagi et al., 2005). 
 
Characterization of antibiotic resistance genes 
Specific primers were used to amplify the various blaBLEE genes 
(blaCTX-M, blaSHV, and blaTEM) (Oteo et al., 2006). Multiple PCR analysis was 
used to study genes that code for AmpC-type plasma β-lactamases  (Pérez-
Pérez  and Hanson, 2002). 
 
Sequencing 
Amplified DNA was obtained by PCR and placed in a sequencer. For 
each PCR run, the corresponding primer was used at 10 μM. Sequences were 
analyzed via the program SeqMan análysis sofware DNA and  pág web 
BLAST® (Basic Local Alignment Search Tool). 
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Molecular epidemiology 
Genetic correlation was performed between the K. pneumoniae 
isolates by pulsed-field gel electrophoresis (PFGE) after complete digestion 
of DNA with XbaI. Some strains representing the primary clusters detected 
by PFGE were typed via MLST, following instructions from the Pasteur 
Institute(http://www.Pasteur.Fr/recherche/genopole/PF8/Mist/K.pneumoniae.
html; last accessed December, 2013). 
 
Results 
In total, we studied 39 isolates of third-generation cephalosporin-
resistant K. pneumoniae strains. Of the 39 isolates, 16 were isolated from the 
NHRU between February and June 2007, including nine from infants with 
sepsis, six from environmental samples, and one from hospital staff. 
Fourteen strains were isolated from the NHRU between June and December 
2009, all from infants with sepsis. The remaining nine strains were isolated 
from the AICU between June and December 2009, from six adult patients 
with sepsis and three from adult patients with pneumonia. 
Of the 16 strains obtained from the NHRU in 2007, 12 (75%) 
presented the same resistance profile, characterized by resistance to 
amoxicillin/clavulanic acid, ampicillin/sulbactam, cefotaxime, ceftazidime, 
cefepime, aztreonam, gentamicin, and tobramycin, as well as sensitivity to 
cefoxitin, piperacillin-tazobactam, amikacin, ciprofloxacin, cotrimoxazole, 
and carbapenems. The remaining four strains (25%) presented a different 
antibiotype, although all strains showed a phenotype compatible with ESBL 
production. The 14 isolates from infant bacteremia in 2009 showed different 
antibiotypes than those of strains isolated in 2007, but most of them (12/14, 
85.7%) presented a phenotype typical of ESBL production. Eight of the nine 
strains (88.8%) isolated from patients in the AICU had an ESBL-producing 
phenotype. The remaining one isolate (11.2%) presented a profile compatible 
with AmpC beta-lactamase production. 
Using PFGE, we detected 12 clusters with over 85% genetic 
homology. Two of them, cluster 1 (C1) and cluster 2 (C2), included 25 of the 
39 strains studied (62.5%). C1 comprised 14 identical strains, including 12 
isolated from the NHRU in 2007 and two isolated from the AICU in 2009. 
C2 comprised 11 strains from the NHRU, including four from 2007 (PFGE 
C2c variant) and seven from 2009 (three PFGE C2a and four C2b variants). 
C3 comprised three strains isolated from the NHRU in 2009. Clusters 4 to 12 
represented individual strains or groups of two strains unrelated to the 
primary clusters (Figure 1). 
An MLST study of strains C1, C2 (with variants C2a, C2b, and C2c), 
and C3 revealed that they belonged to sequence type (ST) 70, ST1261, 
andST23, respectively. This study represents the first reported isolation of 
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ST1261.Of the 39 strains studied, 20 strains (51.28%) produced CTX-M-15, 
eight strains (20.61%) produced CTX-M-2, eight strains (20.61%) produced 
SHV-12, two strains (5.12%) showed hyperproduction of SHV-1, and one 
strain (2.56%) produced EBC. 
In terms of the ESBLs identified in the NHRU, the 12 C1 strains 
(ST70) from 2007 were carriers of blaCTX-M-15. Four were isolated from 
infants, one was isolated from a staff member’s hands, and seven were 
isolated from the environment. The four blood isolates of C2 (ST1261) from 
2007 were carriers of blaCTX-M-2. Of the 14 strains isolated in 2009 from the 
NHRU, five strains (35.7%) were carriers of blaSHV-12 (twoC2 and one each 
of C8, C9, and C12), four strains (28.6%) were carriers of blaCTX-M-15 
(threeC3 and oneC9), and three strains were carriers of blaCTX-M-2 (C2). 
Finally, two strains were carriers of blaSHV-1 and presented a profile 
compatible with hyperproduction, with C2 predominating (ST1261) (Table 
1, Figure 1). 
Regarding the ESBLs identified in the AICU, four of the nine strains 
were carriers of blaCTX-M-15 (two C1, namely ST70, prevalent in the NHRU in 
2007; and two C7), three strains were carriers of blaSHV-12(C5, C11, and 
C12), one strain contained blaCTX-M-2 (C6), and one strain contained blaEBC 
(C4), which codes for the plasmid AmpC beta-lactamase (Table 1, Figure 1). 
Table 1. Characteristics of K. pneumoniae strains isolated in newborns and adults with 
nosocomial infection in the NHRU and AICU  between February and June 2007, and between 
June and November 2009. 
 
Strains  N° 
 
Date 
 
Room 
 
Sample 
 
Type of ESBL 
 
Perfil 
PFGE 
 
ST 
1(24) 18/02/2007 NHRU (A) Blood CTX-M-15 1 70 
2(25) 19/02/2007 NHRU (A) Blood CTX-M-15 1 70 
3(26) 19/02/2007 NHRU (A) Blood CTX-M-15 1 70 
4(27) 19/02/2007 NHRU (A) Blood CTX-M-15 1 70 
5(28) 21/02/2007 NHRU (A) Blood CTX-M-15 1 70 
6 (Soap G) 27/02/2007 Depósito Environment CTX-M-15 1 70 
7 (Soap T) 27/02/2007 NHRU (t) Environment CTX-M-15 1 70 
8 (Soap A) 27/02/2007 NHRU (A) Environment CTX-M-15 1 70 
9 (Soap B) 27/02/2007 NHRU (B) Environment CTX-M-15 1 70 
10 Hands 27/02/2007 Personal Personal CTX-M-15 1 70 
11 Sink 27/02/2007 NHRU (A) Environment CTX-M-15 1 70 
12 handle 27/02/2007 NHRU (A) Environment CTX-M-15 1 70 
13(263) 09/05/2007 NHRU (T) Blood CTX-M-2 2C 1261 
14(268) 11/05/2007 NHRU (A) Blood CTX-M-2 2C 1261 
15(270) 16/06/2007 NHRU (A) Blood CTX-M-2 2C 1261 
16(273) 20/07/2007 NHRU (A) Blood CTX-M-2 2C 1261 
17(79) 18/06/2009 NHRU (A) Blood SHV-12 9A - 
18(88) 19/06/2009 NHRU (A) Blood CXT-M-15 9B - 
19(123) 21/06/2009 NHRU (A) Blood SHV-12 10 - 
20(162) 25/06/2009 NHRU (A) Blood SHV-12 2B 1261 
21(164) 28/06/2009 NHRU (A) Blood SHV-12 2B 1261 
22(218) 29/06/2009 NHRU (A) Blood CTX-M-15 3B 23 
23(220) 13/07/2009 NHRU (A) Blood CTX-M-15 3A 23 
24(228) 17/07/2009 NHRU (A) Blood CTX-M-15 3A 23 
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25(234) 27/07/2009 NHRU (B) Blood HIP.SHV-1 2A 1261 
26(416) 15/08/2009 NHRU (T) Blood CTX-M-2 2B 1261 
27(577) 20/08/2009 NHRU (A) Blood CTX-M-2 2A 1261 
28(578) 23/08/2009 NHRU (A) CSF CTX-M-2 2A 1261 
29(580) 09/09/2009 NHRU (T) Blood HIP. SHV-1 2B 1261 
30(620) 11/10/2009 NHRU (A) Blood SHV-12 8 - 
31(09) 03/07/2009 AICU BS CTX-M-2 6 - 
32(016) 05/07/2009 AICU Blood EBC 4 - 
33(022) 07/07/2009 AICU Blood CTX-M-15 1 70 
34(023) 21/07/2009 AICU Blood CTX-M-15 1 70 
35(025) 28/07/2009 AICU Blood CTX-M-15 7 - 
36(028) 04/08/2009 AICU BS CTX-M-15 7 - 
37(040) 13/08/2009 AICU Blood SHV-12 5 - 
38(041) 16/11/2009 AICU Blood SHV-12 11 - 
39(044) 25/11/2009 AICU Blood SHV-12 12 - 
NHRU (A): Neonatal  intensive care unit A room                 AICU: Adult intensive care unit 
NHRU (B). Neonatal  intensive care unit B room                  CSF: Cerebrospinal fluid 
 NHRU (T): Neonatal  intensive care unit therapy room        BS: Bronchial secretion 
 HIP. SHV-1: Hyperproduction of  SHV-1.   
 
Figure 1. Tree diagram illustrating the genetic relationship between  K. pneumoniae strains producing 
CTX-M-15, CTX-M-2, and SHV-12 beta-lactamases, as well as SHV-1 and plasmid EBC 
hyperproduction in the NHRU and AICU at  LAUH. 
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Discussion 
K. pneumoniae has been one of the principal pathogens causing 
neonatal sepsis in the NHRU at LAUH. Despite the implementation of 
measures for controlling and preventing nosocomial infection, the rate of K. 
pneumonia isolation continues to increase due to patient overcrowding (the 
NHRU of LAUH is the only public neonatology service available in the 
Andes region of the country).  Thus, periodic outbreaks continue to occur, 
such as the outbreak at the end of February 2007 that affected five infants 
hospitalized in the same location over a period of 10 days (González et al., 
2011). 
The ESBL-producing C1/ST70 CTX-M-15 clone was responsible for 
the 2007 outbreak. The C2/ST1261 CTX-M-2–producing clone also 
circulated and was isolated as the predominant clone in the unit in 2009, in 
this case producing different ESBLs. There was no predominant clone in the 
AICU. However, the ST70 clone isolated in the NHRU did spread to the 
AICU, where an EBC AmpC-producing K. pneumoniae strain was also 
isolated. In prior studies in the NHRU, K. pneumoniae strains isolated during 
a 1998–1999 outbreak carried genes coding for the production of two β-
lactamases, one SHV-5 and one TEM-1, as well as others determining 
resistance to aminoglycosides, chloramphenicol, and tetracycline (Araque 
and Rivera, 2004) . A subsequent study in the AICU found that three K. 
pneumoniae strains isolated from infected infants were carriers of CTX-M-1 
and CTX-M-2 (Millan et al., 2013) Other national studies in Venezuela 
reported that four K. pneumoniae strains isolated from patients with 
nosocomial infection in the “Antonio Patricio de Alcalá” University Hospital 
in Cumaná were CTX-M-2 producers (Guzman et al., 2009). This same 
enzyme was reported in Enterobacteriaceae isolated from hospitals in 
Caracas (Torres et al., 2006).  
Some strains isolated from both the NHRU and AICU were CTX-M-
2 producers. However, this is the first time that strains producing both CTX-
M-15 and SHV-12 are reported together in the two most important units of 
LAUH. These two enzymes have frequently been reported in Europe, where 
they are more prevalent than in the United States (Coque  et al., 2008).  
CTX-M-15 predominates in Western Europe, the United Kingdom, Italy, 
France, and Portugal, where its presence has grown rapidly (Cantón et al., 
2008; Livermore et al., 2007). A recent study in Venezuela on the frequency 
and diversity of CTX enzymes in Enterobacteriaceae isolates,  found that 
CTX-M-1 was the most common (91%) followed by CTX-M-2, whereas 
there was a lower percentage of CTX-M-15  and CTX-M-14 . This recent 
study was the first to report CTX-M-15– and CTX-M-14–producing 
Enterobacteriaceae in Caracas, Venezuela (Redondo et al., 2013).  
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In the present study, we provide the first report of CTX-M-15–
producing K. pneumoniae strains associated with an NHRU outbreak in 
Mérida, which spread to another intensive care unit at LAUH. The 
predominance of the C1/ST70 clone among strains isolated in the NHRU 
during the 2007 outbreak and its presence in two AICU strains in 2009 show 
that this epidemic clone circulated in the hospital at different times and in 
different units, indicating its ability to produce periodic outbreaks. 
The possible generalization of CTX-M-15 has been reported in 
Argentina. This clone often associates with other clones across the world, 
such as E. coli ST131 and K. pneumoniae ST11 (Sennati et al., 2012; Diestra 
et al., 2009). Other STs capable of producing and spreading CTX-M-15 have 
been described, such as ST15, which produced epidemic outbreaks in 
Hungary (Damjanova et al., 2008). Likewise, in studies on CTX-M-15–
producing K. pneumoniae strains from infants and adults in Spain, the most 
prevalent STs were ST1, ST11, ST13, ST14, ST15, ST16, ST20, ST35, 
ST36, and ST134 (Oteo et al., 2009). Here, we describe the C2/ST126 clone 
for the first time at a global level. Strains of this clone produce different 
types of ESBLs, suggesting the possible plasmidic dissemination of bla 
genes in a previously predominant sensitive clone.  
 
Conclusion 
In conclusion, the results of our study indicate that different ESBL-
producing K. pneumoniae clones (ST70, ST1261, and ST23) circulated in the 
NHRU and AICU of LAUH in Mérida, Venezuela. Clones ST70 and ST23 
produced the CTX-M-15 ESBL, described for the first time in Venezuela. 
The CTX-M-2– and SHV-12–producing clone ST1261 is described for the 
first time at a global level. 
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